Opus Point Partners Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$542K Hold
2019
Q2
$622K Hold
2019
Q1
$472K Buy